Canada markets open in 1 hour 50 minutes

Novartis AG (NVS)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
83.73-0.55 (-0.65%)
At close: 04:00PM EDT
84.49 +0.76 (+0.91%)
Pre-Market: 07:23AM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close84.28
Open83.60
Bid84.55 x 1000
Ask84.61 x 800
Day's Range83.18 - 84.01
52 Week Range79.09 - 95.17
Volume1,777,021
Avg. Volume2,400,263
Market Cap185.518B
Beta (5Y Monthly)0.50
PE Ratio (TTM)7.82
EPS (TTM)10.71
Earnings DateN/A
Forward Dividend & Yield3.33 (3.97%)
Ex-Dividend DateMar 08, 2022
1y Target Est104.40
  • Zacks

    Novartis (NVS) Announces Positive Data on Oncology Drug

    Novartis' (NVS) anti-PD-1 monoclonal antibody, tislelizumab, significantly extends median overall survival in first-line advanced esophageal cancer combined with chemotherapy.

  • Zacks

    The Zacks Analyst Blog Highlights Sanofi, Merck, Novartis, Pfizer and J&J

    Sanofi, Merck, Novartis, Pfizer and J&J are part of Zacks top Analyst Blog.

  • Bloomberg

    Novartis Leaning Toward Spinoff of $25 Billion Generics Arm

    (Bloomberg) -- Novartis AG is leaning toward a spinoff of its generic-drug unit, as a challenging environment for leveraged buyouts makes a potential sale to private equity more difficult, people familiar with the matter said. Most Read from BloombergUS Will Face High Gas Prices ‘as Long as It Takes,’ Biden SaysThe Wheels Have Come Off Electric VehiclesCrypto Meltdown Claims Rolex and Patek Philippe as VictimsStock Doomsayers Vindicated in Historic First Half: Markets WrapUkraine Latest: Kyiv La